HopeStage
Back to all studies
RecruitingNCT02431845

Biological factors linked to SSRI response in OCD

About this title

Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder

Read the official source — NCT02431845
Medication studyAges 19–70South Korea
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 70 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2013
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
Severance Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
South Korea
Age range
From 19 Years to 70 Years
Official registry ID
NCT02431845
Official title
Show the full official title

Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive

Recruitment & locations

Currently recruiting

Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Severance Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including SSRIs.

Who can participate?

Listed age limits: 19 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies